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ABSTRACT 
Objective: The present study involved the preparation of Interpenetrating Polymer Network (IPN) microspheres formulated from Poly (vinyl 
alcohol) (PVA) and Methyl Cellulose (MC) for controlled release of an anti-cancer drug, 6-thioguanine. 
Methods: The IPN microspheres were prepared by water-in-oil emulsion method using gluteraldehyde as a cross-linker. 6-thioguanine drug was 
successfully loaded into these microspheres via in-situ process. These prepared microspheres were characterized by Fourier transform infrared 
spectroscopy (FTIR), differential scanning calorimetry (DSC), X-ray diffraction (X-RD), optical microscopy (OM) and Scanning electron microscopy 
(SEM). 
Results: FTIR spectral data results confirmed the cross-linking reaction between IPN microspheres through gluteraldehyde. DSC and X-RD results 
indicated the molecular level distribution of 6-thioguanine drug in the polymer matrix. SEM images showed the microspheres have spherical shape 
with rough surface. OM results gave the average size of prepared microspheres that ranged from 40 to 280 µm. Encapsulation efficiency of the drug 
in these IPN microspheres was found to be 72 %. In vitro dissolution studies performed at pH 7.4 buffer medium showed that the drug release was 
depended on the extent of cross-linker, drug and the percentage of PVA used in the formulations. The drug release was analyzed by an empirical 
equation and was found to be non-Fickian type diffusion. 
Conclusion: This study reveals that the combination of PVA and MC in the form of IPN microspheres may be used successfully for the controlled 
release of drugs with short plasma half-life. In vitro release studies showed the extended release of the drug for more than 12 h. 
Keywords: Poly (vinyl alcohol), Methyl Cellulose, 6-thiogauanine, Interpenetrating Polymer Network Microspheres, In vitro release studies. 
 
INTRODUCTION 
Drug delivery research is primarily focused on targeted delivery of 
the drug to the desired organ system to minimize toxicity and 
maximize therapeutic efficacy. As oral route is the most popular 
route of drug administration, a large emphasis is given on the 
development of controlled oral drug delivery systems. Drug 
substances with high water solubility and short half life (elimination 
half-life 2-3 h) get readily absorbed and eliminated, thus requiring 
frequent [1]. This may lead to decrease in patient compliance and 
increase chances of side effects due to dose dumping [2, 3].  
Thus, the drugs having high water solubility and short half-life 
warns extensive research to reduce frequent dosing and dose 
related side effects by controlling their release rate. Fabrications of 
drug delivery devices like microparticles or nanospheres are some 
of the approaches to control the release of highly water soluble 
drugs. Recently researchers have given a strong emphasis on natural 
polymer based approaches to develop controlled drug delivery 
systems. The use of synthetic polymers for drug delivery purposes is 
of limited application due to problems in biodegradability, use of 
organic solvents resulting in environmental pollution etc. [4]. 
However, natural polymers are considered to be much safer since 
organic solvents are not required for their processing and they are 
biodegradable in nature [5, 6]. The use of these natural polymers 
have their own problems like uncontrolled swelling and premature 
release of loaded drug. 
The concept of polymeric blend microspheres is quite effective in 
overcoming the above problems. Interpenetrating polymer network 
(IPN) is one such formulation which is considered to be promising in 
delivery of bioactive molecules, particularly in controlled release 
applications [7]. IPN’s have been recognized as popular responsive 
polymers having enhanced physical properties, easy fabrication of 
devices, manipulation of device properties, etc., as compared with 
conventional blends of their components. This would open up 
avenues to use IPN’s in designing the novel controlled release 
systems. A combination of judicially selected natural and synthetic 
polymers based IPN’s has been found to be useful in enhancing the 
release of short half-lived drugs under physiological conditions. In 
order to achieve this, the blending of natural and synthetic polymers 
has been modified by grafting, blending and other means [8]. 
Blending of synthetic polymers with cellulose and modified cellulose 
are widely accepted [9, 10]. Recently our laboratory developed 
modified IPN-based carbohydrate polymers for CR systems of 
various types of drugs [11-13]. 
Methylcellulose (MC) is a cellulose derivative that has been 
extensively investigated for biomedical applications. It is a food 
additive used as a thickening agent and is unique due to its 
thermoreversibility characteristics. It exhibits low viscosity at low 
temperatures and a higher viscosity at higher temperatures as the 
polymer chains dehydrate and interact with each other. MC is 
biocompatible and its gelling properties have been well studied [14, 
15, 16-18]. MC has been proven to support some nerve regeneration 
and can also be linked with proteins which encourage axonal 
extension [19]. Mixtures of MC with hyaluronan have recently been 
shown to change the properties of methylcellulose and provide a 
new hydrogel with regenerative abilities [15]. 
Poly (vinyl alcohol) (PVA) has been used widely in a variety of fields 
since its discovery in 1924 [20] due to its desirable properties such 
as non-toxicity and non-carcinogenicity [17]. It finds extensive 
applications as biomaterials [21-23], such as contact lenses, artificial 
blood vessels, artificial intestines [20], and kidneys [22]. Drug 
release studies have also been carried on PVA-based hydrogels, a 
biocompatible, chemically stable, and desirable for bioseparations 
and cell encapsulations [21, 23, 24]. However, PVA is a highly 
hydrophilic polymer and has poor stability in water, so its solubility 
must be prevented for use in aqueous systems. To overcome this 
problem, PVA should be insolubilized by blending [25], 
copolymerization [26], grafting [27, 28] and cross-linking [29]. 
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 Hence in the present study PVA is blended with a natural polymer, 
MC and incorporated with an anticancer drug for drug release study. 
6-thioguanine, chemically known as 2-amino-6-mercaptopurine 
belongs to the thiopurine family of drugs which is an example of 
antimetabolite. It is a purine analogue of the nucleobase guanine and 
used as an anticancer drug. Its drug usage was originally as a 
cytostatic agent in chemotherapy for the treatment of acute 
lymphoblasic leukemia in children [30]. The plasma half-life of 
thioguanine is short, due to the rapid uptake into liver and blood 
cells. From a perusal of the literature it was found that no reports 
are available on MC/PVA IPN microspheres for CR of 6-thioguanine 
drug. This prompted us to incorporate water soluble 6-thioguanine 
drug into MC/PVA IPN microspheres. The authors successfully 
studied the release profiles for different formulations by varying 
PVA content in MC/PVA blend, cross-linking agent and drug 
concentration.  
MATERIALS AND METHODS 
Materials 
Methyl cellulose (MC) (Mn ����� ≈ 40,000, degree of methylation = 1.6-
1.9), Poly (vinyl alcohol) (PVA) (Mn ����� ≈ 1,25,000) and 6-thioguanine 
were purchased from Sigma – Aldrich, USA. Analytical reagent grade 
of Gluteraldehyde solution (25% v/v), n-hexane, petroleum ether (B. 
P = 60 – 80 0
Preparation of IPN Microspheres 
C), Span-80, hydrochloric acid (HCl) and Paraffin Oil 
(light) were purchased from S. D. Fine chemicals, Mumbai, India. 
IPN microspheres of MC and PVA were prepared by W/O emulsion 
cross – linking method. In brief, known amount of PVA was 
dissolved in distilled water by continuously stirring at 80 0
This solution was slowly added to a mixture of petroleum ether and 
light liquid paraffin (40:60, w/w) containing Span-80 (1% w/w) 
under constant stirring at 400 rpm speed for 10 min. To this 
emulsion, 1 mL of 0.1 M HCl and the known amount of GA was added 
slowly and further stirred for another 30 min. The hardened 
microspheres were separated by filtration, washed with n-hexane 
and water to remove oil and excess amount of unreacted GA. These 
microspheres were dried under vacuum at 40 
C until a 
homogeneous solution was obtained. After cooling to ambient 
temperature, known amount of MC solution (obtained by dissolving 
separately in water by stirring overnight) was added in the above 
PVA solution and stirred overnight to obtain a clear solution. Then, 
known amount of 6-thioguanine drug dissolved in water was added 
to the blend polymer solution.  
0
Fourier Transform Infrared (FTIR) Spectroscopy 
C for 24 h and stored 
in desiccator for further analysis and characterization. In total, seven 
formulations were prepared by varying the drug concentration, 
cross – linker (GA) and % of PVA according to the Table 1. 
Representation of IPN microsphere is shown in Scheme 1.  
The FTIR spectra of pure PVA, pure MC, pure drug, pure IPN 
microspheres and drug- loaded IPN microspheres were recorded 
using FTIR spectrophotometer (Model impact 410, Wisconsin, MI, 
USA). The samples were crushed finely with potassium bromide 
(KBr) to make pellets under hydraulic pressure of 700 dynes/m2 
and scanned between 4000 and 400 cm-1
Differential scanning colorimetry 
. 
DSC curves of pure MC/PVA microspheres, drug-loaded MC/PVA 
microspheres and pure drug were recorded using a DSC (Model – 
SDT Q600, USA) by heating from 40 to 600 0C at a heating rate of 10 
0
X-ray diffraction studies 
C/min under nitrogen atmosphere (flow rate, 20 ml/min). 
X-Ray diffraction (X-RD) patterns of pure MC/PVA microspheres, 
drug-loaded MC/PVA microspheres and pure drug were recorded 
using a Rigaku Giegerflex diffractometer (Tokyo, Japan) equipped 
with Ni-filtered CuKα radiation (λ = 1.5418 A0) at 40 kV and 50 mA. 
The dried microspheres of uniform size were mounted on a sample 
holder, and the patterns were recorded in the 2θ range of 0- 60
 
0 
Scheme 1: Formation of 6-thioguanine encapsulated IPN 
microsphere by the cross – linking reaction between PVA and 
MC using GA. 
 
Particle Size and Scanning Electron Microscopy 
To determine the particle size and size distribution, ~ 100-200 
microspheres were taken on a glace slide and their sizes were 
measured using an optical microscope under regular polarized light. 
Scanning electron microscope (SEM) micrographs of IPN 
microspheres were obtained using JEOL Model, JSM-6360, Kyoto, 
Japan at the required resolution (Mag 100 x 30 kv). 
Estimation of Drug Loading and Encapsulation Efficiency 
The drug-loaded microspheres (10 mg) were pulverized and 
incubated in 10 mL of phosphate buffer (pH 7.4) at room 
temperature for 24 h. The suspension was agitated with agate 
mortar and filtered through filter paper. The drug solution was 
assayed spectrophotometrically for 6-thioguanine content at the 
wavelength of 340 nm. The results of % drug loading and 
encapsulation efficiency were calculated using following equations 
% Drug loading =  �Amount of drug in microspheres
Amount of microspheres
�  × 100 …………..…. (1) 
% Encapsulation efficiency =  � Actual loading
Theoretical loading
�  × 100……………. (2) 
In vitro release studies 
In vitro dissolution studies were carried out in phosphate buffer 
solution (pH 7.4) using Tablet dissolution tester (Lab India, Mumbai, 
India) equipped with eight baskets. Dissolution rates were measured 
at 37 ± 0.5 0C at constant speed of 100 rpm. At regular time intervals, 
aliquot samples were withdrawn and analyzed using UV 
spectrophotometer (Lab India, Mumbai, India) at the fixed λmax 
RESULTS AND DISCUSSIONS 
value 
of 340 nm. After each sample collection, the same amount of fresh 
medium at the same temperature was added to the release medium 
to maintain the sink condition. All measurements were carried out in 
triplicate, and values were plotted with standard deviation errors. 
Fourier transform infrared spectroscopy 
Fig 1 shows the FTIR spectral analysis of pure microspheres (a). 
Drug loaded microspheres (b) and pure drug (c). These spectra were 
used to examine the stability of the drug in the formulation and to 
confirm the formation of IPN matrix structure. 
Subha et al. 




FTIR spectra of pure microspheres and drug loaded microspheres 
(Fig 1a, 1b) shows the characteristic absorption band at 3440 cm-1 
due to the – O – H stretching vibration and a peak at 2962 cm-1 was 
due to the – C –H stretching vibrations. The peak at 1134 cm-1
The FTIR bands (Fig 1c) present at 1482 cm
 in the 
pure microspheres (Fig 1a) indicates the formation of acetal 
between PVA and MC due to crosslinking by GA. Similar finding has 
been observed elsewhere [31].  
-1 and 1535 cm-1 in 6-
thioguanine are assigned to aromatic C – C symmetric and 
asymmetric stretching vibrations, the IR bands observed at 3263 cm-
1 and 3309 cm-1 were assigned to N-H symmetric and asymmetric 
vibrations. The bands at 1373 cm-1 and 1434 cm-1
 
 are assigned to C-
N symmetric and asymmetric stretching vibrations [32]. In the case 
of drug loaded microspheres (Fig 1b) all the peaks corresponding to 
pure microspheres and 6-thioguanine were present, which provided 
the physical stability of drug in the formulation.  
 
Fig. 1: FTIR spectra of (a) pure microspheres, (b) drug loaded 
microspheres and (c) pure 6-thioguanine. 
 
DSC Analysis 
DSC thermograms of the pure 6-thioguanine drug (a), pure 
microspheres (b), and drug loaded microspheres (c) are displayed in 
Fig 2. The onset melting peak of 6-thioguanine was observed at 
384.35 0
 
C (Fig 2a). However, no characteristic peak of 6-thioguanine 
was observed in the DSC curves of the drug loaded microspheres, 
suggesting that the drug is molecularly dispersed in the polymer 
matrix. 
 
Fig. 2: DSC thermograms of (a) pure 6-thioguanine, (b) pure 
microspheres and (c) drug loaded microspheres. 
 
Particle Size and Scanning Electron Microscopic Studies 
SEM images of few drug loaded blend IPN microspheres are shown 
in Fig 3. The microspheres are spherical without forming 
agglomeration and their surfaces are slightly rough. The results of 
particle size of microspheres were in the range of 40 – 280 µm. The 
variation of particle size with polymer composition and GA content 
are shown in Fig 4a, 4b respectively. As % of PVA increases the 
average size of microspheres decreased. This may be due to the fact 
that PVA produces a compact network of macromolecular chains in 
the blend IPN microspheres, which tightens the network and hence 
decrease in size was observed. As GA content increases the average 
size of microspheres decreases. This was due to the increased 




Fig. 3: SEM micrograph of drug loaded IPN microspheres. 
 
 
Fig. 4: Size and size distribution of IPN microspheres (a) effect 
of PVA, and (b) effect of GA content. 
 
X-Ray Diffraction Studies 
X-ray diffractograms of (a) pure 6-thioguanine, (b) pure 
microspheres, and (c) drug loaded microspheres are showed in Fig 
5. These studies are useful to investigate the crystallinity of drug in 
the cross linked microspheres. The diffractogram of pure drug has 
shown characteristic intense peaks between 2θ of 100 and 270 
 
due to 
its crystalline nature.  
 
Fig. 5: X-RD patterns of (a) pure 6-thioguanine, (b) pure 
microspheres and (c) drug loaded microspheres. 
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However, these peaks have disappeared in the drug loaded 
microspheres, but only peaks observed in pure microspheres were 
seen. This indicates the molecular dispersion of the drug after 
incorporation into the IPN microspheres. These results are in 
accordance with the conclusions drawn above from DSC results 
explained earlier. 
Encapsulation Efficiency 
Effects of GA and PVA content on encapsulation efficiency of drug-
loaded microspheres are given in Table 1. The encapsulation 
efficiency of 6-thioguanine drug decreases with increasing PVA 
content in the formulations. This is due to the fact that at higher 
concentrations, PVA produced a compact network of 
macromolecular chains during the microspheres formation. Hence, 
increasing content of PVA in the PVA/MC blend microspheres 
decrease trend in drug encapsulation efficiency was observed. 
Microspheres cross-linked with 2.5, 5 and 7.5 mL of GA, 
encapsulation efficiencies are 72%, 63%, and 61% respectively. 
Such decreasing trend is due to an increase in cross-link density, 
resulting in the formation of a more rigid network structure, which 
reduces the free volume spaces within the polymer matrix and 
hence, a reduction in encapsulation efficiency is observed. 
 









Amount of GA added 
(mL) 
% of E. E ± S. 
D 
n k Correlation 
coefficient, r 
PM-1 90 10 10 5 70.3±0.4 0.71 0.0136 0.9612 
PM-2 80 20 10 5 68.1±1.2 0.64 0.0152 0.9833 
PM-3 70 30 10 5 63.9±0.7 0.59 0.0242 0.9454 
PM-4 70 30 20 5 66.4±1.1 0.55 0.0311 0.9758 
PM-5 70 30 30 5 68.7±0.8 0.48 0.0167 0.9879 
PM-6 70 30 10 7.5 61.6±2.7 0.66 0.0174 0.9918 
PM-7 70 30 10 2.5 72.3±1.6 0.62 0.0565 0.9445 
E. E = Encapsulation efficiency; S. D = Standard deviation  
 
Drug Release Kinetics 
Drug release kinetics was analyzed by plotting cumulative release 
data versus time and fitting these data to the exponential equation of 
the type [33]: 
Mt
M∞
=  ktn  ………………………(3) 
Here Mt/M∞
In this study, the values of k and n have shown a dependence on the 
extent of cross-linking, % drug loading, and PVA content of the 
matrix. Values of n for microspheres prepared by varying the 
amount of PVA in the microspheres of 10, 20, and 30 wt% by 
keeping 6-thioguanine (10 wt%) and GA (5 mL) constant, ranged 
from 0.59 to 0.71 (see Table 1) leading to the drug diffuses and 
erosion controlled release from the polymer matrix following a non-
Fickian type diffusion.  
 represents the fractional drug release at time t; k is a 
constant characteristic of the drug-polymer system and n is an 
exponent parameter characterized the release mechanism. Using the 
least squares procedure, we have estimated the values on n and k for 
all the formulations, and these values are given in Table 1. If n = 0.5, 
drug diffuses and releases out of the polymer matrix following the 
Fickian diffusion. For n > 0.5, anomalous or non-Fickian type drug 
diffusion occurs, if n = 1, a completely non Fickian or case II release 
kinetics is operative. The intermediary values ranging between 0.5 
and 1.0 are attributed to the anomalous type of diffusive transport 
[33]. 
This may be due to the reduction in the regions of low 
microviscosity and closure of microcavities in the swollen state of 
the polymer. Similar findings have been observed elsewhere [34]. 
Correlation coefficients, r, obtained while fitting the release data are 
in the range from of 0.9445 to 0.9918. 
In vitro drug release studies 
Effect of Drug Content 
The release profiles of 6-thioguanine drug loaded MC/PVA IPN 
microspheres at different amounts of drug loading are shown in Fig 
5. Release data showed that PM-5 formulation containing a higher 
amount of the drug (30%) displayed fast and higher release rates 
compared to the formulation PM-3, which is having small amount of 
the drug (10%). In other words, with a decreasing amount of drug in 
the matrix, it is observed that the release rate becomes quite slower 
due to the availability of more free void spaces through which a 
lesser number of drug molecules could transport. 
 
Fig. 5: % Cumulative release of 6-thioguanine through IPN 
microspheres containing 70:30 ratio of MC/PVA with different 
amount of 6-thioguanine (PM-3) 10%, (PM-4) 20%, and (PM-5) 
30%. 
 
Effect of Crosslinking Agent 
The cumulative release vs. Time curves for varying amounts of GA 
(2.5, 5, 7.5 mL) at a fixed amount of drug (10 wt %), MC/PVA 
microspheres PM-7, PM-3, and PM-6 are displayed in Fig 6. The % of 
cumulative release is quite faster and larger at lower amount of GA 
(2.5 mL) (PM-7), whereas the release is quite slower at higher 
amount of GA (i. e. 7.5 mL) (PM-6). The cumulative release is slower 
when the microparticles containing the higher amount of GA, it may 
be due to the polymeric chains become rigid due to the contraction 
of microvoids, thus decreasing the % cumulative release of 6-
thioguanine drug through the microspheres. 
Effect of PVA Content  
To understand the effect of PVA content on the release profiles of 6-
thioguanine from cross linked MC/PVA blend microspheres, In vitro 
release studies was carried out in pH 7.4 phosphate buffer solution 
at 37 0C. Fig 7 shows the cumulative release of drug (10 wt%) 
through microspheres containing different ratios of MC/PVA, at a 
constant GA (5%) concentration. From Fig 7 it was found that the 
highest cumulative release is obtained for PM-1 formulation, which 
has 10 % PVA ratio. On the other hand, the least cumulative release 
is obtained in PM-3, which has 30 % PVA ratio. 
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Fig. 6: % Cumulative release of 6-thioguanine through IPN 
microspheres containing 70:30 ratio of MC/PVA and 10% drug 
with different amount of GA (PM-7) 2.5 mL, (PM-3) 5.0 mL, and 
(PM-6) 7.5 mL. 
 
This is due to the fact that PVA is virtually a linear polymer with 
small hydrate groups and thus produces a compact network of 
macromolecular chains in the blend microspheres, where as MC is a 
natural water-soluble polymer and contains residual –OH groups, 
which imparts hydrophilicity to the macro-molecule. Hence, with an 
increase of PVA in the PVA/MC blend microspheres a decrease in % 
of cumulative release is observed.  
 
 
Fig. 7: % Cumulative release of 6-thioguanine through IPN 
microspheres containing 10% of drug and 5 mL of GA with 
variation of PVA (PM-1) 10%, (PM-2) 20%, and (PM-3) 30%. 
 
CONCLUSION 
MC/PVA IPN blend microspheres loaded with 6-thioguanine were 
prepared by W/O emulsion method using span-80 as the surfactant. 
The molecular level dispersion of drug, in the drug loaded 
microspheres was confirmed by DSC analysis. SEM images have 
shown the formation of spherical microspheres with the rough 
surface. Particle size measurements using optical microscopy gave 
an average size of 40-240 µm. The encapsulation efficiency was 
found to vary between 61% and 72% depending upon the blend 
composition, cross-linking and the amount of drug loading. Drug 
release studies indicated controlled release of 6-thioguanine for 
more than 10 h from IPN microspheres. 
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